Retatrutide 10mg

Description

Retatrutide 10mg is a research-grade peptide manufactured to ≥99% HPLC purity, third-party verified, and shipped cold-chain across the EU. Each vial is sealed, batch-traced, and accompanied by a Certificate of Analysis (CoA) on request.

Compound Specifications

• CAS Number: 2381089-83-2
• Molecular Formula: C221H342N46O68
• Purity: ≥99% (HPLC)
• Form: Lyophilised powder (vial)
• Storage: 2–8 °C refrigerated; protect from light

Research Application

Retatrutide is a triple agonist research peptide acting on GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical literature (Jastreboff et al., NEJM 2023) demonstrates the most aggressive body composition shifts of any GLP-1 class compound studied to date. Research applications include comparative metabolic studies, body composition trials, and triple-mechanism receptor research.

Dosing & Reconstitution Notes

Reconstitute with 1ml sterile bacteriostatic water for laboratory protocols. Reconstituted material stable refrigerated for 28 days. Research dosing typically 2–8 mg per week range in published trials.

Quality Assurance

Every batch of Retatrutide 10mg sold by Chempeptides is verified via independent HPLC and mass spectrometry analysis. Karl Fischer titration confirms moisture content. Cold-chain logistics protect peptide integrity from lab to lab. CoA available on request.

For research-use only. Not for human consumption. Not a medicine. Not for diagnostic use.